Laboratory Of Stock Beneish M Score

LH Stock  USD 240.17  2.32  0.98%   
This module uses fundamental data of Laboratory to approximate the value of its Beneish M Score. Laboratory M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis.
  
As of now, Laboratory's Debt To Equity is decreasing as compared to previous years. The Laboratory's current Interest Debt Per Share is estimated to increase to 65.41, while Short and Long Term Debt Total is projected to decrease to under 3 B. As of now, Laboratory's Free Cash Flow Yield is decreasing as compared to previous years. The Laboratory's current Operating Cash Flow Per Share is estimated to increase to 16.01, while Price To Sales Ratio is projected to decrease to 1.57.
At this time, Laboratory's M Score is unavailable. The earnings manipulation may begin if Laboratory's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Laboratory executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Laboratory's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.07
Beneish M Score - Unavailable
Elasticity of Receivables

1.0

Focus
Asset Quality

0.99

Focus
Expense Coverage

0.5

Focus
Gross Margin Strengs

1.52

Focus
Accruals Factor

0.5

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

1.0

Focus

Laboratory Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Laboratory's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables2.2 B2.1 B
Sufficiently Up
Slightly volatile
Total Revenue12.8 B12.2 B
Sufficiently Up
Slightly volatile
Total Assets17.6 B16.7 B
Sufficiently Up
Slightly volatile
Total Current AssetsB3.8 B
Sufficiently Up
Slightly volatile
Non Current Assets Total13.6 B13 B
Sufficiently Up
Slightly volatile
Property Plant Equipment3.6 B3.4 B
Sufficiently Up
Slightly volatile
Depreciation And Amortization609.9 M580.9 M
Sufficiently Up
Slightly volatile
Selling General Administrative1.1 B2.2 B
Way Down
Slightly volatile
Total Current Liabilities3.4 B3.2 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total3.1 B5.6 B
Way Down
Slightly volatile
Short Term Debt1.4 B1.3 B
Sufficiently Up
Pretty Stable
Long Term Debt3.1 B4.1 B
Significantly Down
Slightly volatile
Operating Income820.1 M725.6 M
Moderately Up
Slightly volatile
Total Cash From Operating Activities801.6 M1.3 B
Way Down
Slightly volatile
Long Term Investments25.6 M26.9 M
Notably Down
Slightly volatile
Gross Profit Margin0.420.2767
Way Up
Slightly volatile

Laboratory Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Laboratory's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Laboratory in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Laboratory's degree of accounting gimmicks and manipulations.

About Laboratory Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Current Deferred Revenue

442.79 Million

As of now, Laboratory's Current Deferred Revenue is increasing as compared to previous years.

Laboratory Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Laboratory. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables2.0B3.0B3.0B2.0B2.1B2.2B
Total Revenue11.6B14.0B16.1B14.9B12.2B12.8B
Total Assets18.0B20.1B20.4B20.2B16.7B17.6B
Total Current Assets3.0B5.1B5.3B4.6B3.8B4.0B
Net Debt6.7B5.4B4.9B5.9B5.4B5.7B
Short Term Debt621.1M774.1M396.5M471.1M1.3B1.4B
Long Term Debt5.8B5.4B5.4B5.0B4.1B3.1B
Operating Income1.3B2.4B3.3B1.8B725.6M820.1M
Investments(1.3B)(643.2M)(14.6M)(1.7B)(1.1B)(1.1B)

Laboratory ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.
Environmental
Governance
Social

About Laboratory Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.26
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.